![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 6
Zeitschriftenartikel
Staehler, Michael D.; Battle, Dena J.; Bergerot, Cristiane D.; Pal, Sumanta Kumar und Penson, David F.
(2020):
COVID-19 and financial toxicity in patients with renal cell carcinoma.
In: World Journal of Urology
[PDF, 750kB]
Bergerot, Cristiane Decat; Battle, Dena; Bergerot, Paulo Gustavo; Dizman, Nazli; Jonasch, Eric; Hammers, Hans J.; George, Daniel J.; Bex, Axel; Ljungberg, Borje; Pal, Sumanta Kumar und Staehler, Michael D.
(22. Januar 2019):
Sources of Frustration Among Patients Diagnosed With Renal Cell Carcinoma.
In: Frontiers in Oncology, Bd. 9, 11: S. 1-7
[PDF, 511kB]
Powles, Thomas; Lackner, Mark R.; Oudard, Stéphane; Escudier, Bernard; Ralph, Christy; Brown, Janet E.; Hawkins, Robert E.; Castellano, Daniel; Rini, Brian I.; Staehler, Michael D.; Ravaud, Alain; Lin, Wei; O'Keeffe, Bridget; Wang, Yulei; Lu, Shan; Spoerke, Jill M.; Huw, Ling-Yuh; Byrtek, Michelle; Zhu, Rui; Ware, Joseph A. und Motzer, Robert J.
(2016):
Randomized Open-Label Phase II Trial of Apitolisib (GDC-0980), a Novel Inhibitor of the PI3K/Mammalian Target of Rapamycin Pathway, Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma.
In: Journal of Clinical Oncology, Bd. 34, Nr. 14:
1660-U204
Bex, Axel; Werkhoven, Erik D. van; Noe, Allard; Karam, Jose A.; Matin, Surena F.; Margulis, Vitaly; Stewart, Grant; Staehler, Michael D. und Wood, Christopher G.
(2016):
External validation of a prediction model of survival after cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC).
In: Journal of Clinical Oncology, Bd. 34, Nr. 2
Staehler, Michael D.; Schlenker, Boris; Karl, Alexander; Spek, Annabel und Muacevic, Alexander
(2016):
Single-fraction radiosurgery for the treatment of renal cell carcinoma.
In: Journal of Clinical Oncology, Bd. 34, Nr. 2
Bergmann, Lothar; Goebell, Peter J.; Kube, Ulrich; Kindler, Manfred; Herrmann, Edwin; Janssen, Jan; Schmitz, Joerg; Weikert, Steffen; Steiner, Gabriel; Jakob, Andreas; Staehler, Michael D.; Steiner, Thomas; Overkamp, Friedrich; Albrecht, Michael; Guderian, Gernot und Doehn, Christian
(2013):
Everolimus in Metastatic Renal Cell Carcinoma after Failure of Initial Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor (VEGFr-TKI) Therapy: Results of an Interim Analysis of a Non-Interventional Study.
In: Onkologie, Nr. 3: S. 95-100
[PDF, 441kB]